Differential expression of the α2 chain of the interleukin‐13 receptor in metastatic human prostate cancer ARCaP<sub>M</sub> cells.
Huiguang He(Chinese Academy of Sciences), Ruoxiang Wang(Cedars-Sinai Medical Center), Peter S. Nelson(Fred Hutch Cancer Center), Dalin He(Sichuan University), Haiyen E. Zhau(Cedars-Sinai Medical Center), Leland W.K. Chung(VA Palo Alto Health Care System), Jianchun Xu(Emory University), Fray F. Marshall(Johns Hopkins University)
Cited by 9
Related Papers
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
|New England Journal of Medicine|2016|1.6k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
|Cancer Research|2008|1.4k
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618